- Home
- ACAD vs EQC Comparison
ACAD vs EQC Comparison
Compare ACAD & EQC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ACAD
- EQC
- Stock Information
- Founded
- ACAD 1993
- EQC 1986
- Country
- ACAD United States
- EQC United States
- Employees
- ACAD N/A
- EQC N/A
- Industry
- ACAD Biotechnology: Pharmaceutical Preparations
- EQC Real Estate Investment Trusts
- Sector
- ACAD Health Care
- EQC Real Estate
- Exchange
- ACAD Nasdaq
- EQC Nasdaq
- Market Cap
- ACAD 2.6B
- EQC 2.2B
- IPO Year
- ACAD 2004
- EQC 1986
- Fundamental
- Price
- ACAD $16.30
- EQC $20.17
- Analyst Decision
- ACAD Buy
- EQC
- Analyst Count
- ACAD 19
- EQC 0
- Target Price
- ACAD $26.44
- EQC N/A
- AVG Volume (30 Days)
- ACAD 1.4M
- EQC 3.6M
- Earning Date
- ACAD 11-06-2024
- EQC 10-23-2024
- Dividend Yield
- ACAD N/A
- EQC N/A
- EPS Growth
- ACAD N/A
- EQC N/A
- EPS
- ACAD 0.78
- EQC 0.38
- Revenue
- ACAD $929,236,000.00
- EQC $58,433,000.00
- Revenue This Year
- ACAD $37.34
- EQC N/A
- Revenue Next Year
- ACAD $7.25
- EQC N/A
- P/E Ratio
- ACAD $21.00
- EQC $53.05
- Revenue Growth
- ACAD 47.06
- EQC N/A
- 52 Week Low
- ACAD $14.15
- EQC $17.93
- 52 Week High
- ACAD $32.59
- EQC $21.00
- Technical
- Relative Strength Index (RSI)
- ACAD 51.17
- EQC 55.98
- Support Level
- ACAD $16.02
- EQC $20.07
- Resistance Level
- ACAD $16.68
- EQC $20.35
- Average True Range (ATR)
- ACAD 0.58
- EQC 0.13
- MACD
- ACAD -0.09
- EQC 0.01
- Stochastic Oscillator
- ACAD 25.70
- EQC 73.13
About ACAD ACADIA Pharmaceuticals Inc.
Acadia Pharmaceuticals Inc is a biotechnology company that develops and commercializes biopharmaceutical products to address central nervous system disorders. The company aims to discover small molecules drugs that address disorders such as Parkinson's, Alzheimer's, and schizophrenia. Acadia also seeks to in-license or acquire complementary products and candidates. The company's patent applications claim proprietary technology, including novel methods of screening and chemical synthetic methods, novel drug targets, and novel compounds identified using its technology.
About EQC Equity Commonwealth of Beneficial Interest
Equity Commonwealth is a real estate investment trust engaged in the acquisition, ownership, and operation of office buildings located throughout the United States. The vast majority of the company's real estate portfolio comprises office assets. These properties are fairly evenly dispersed between many of America's urban markets, notably Washington, Austin, and Denver. Equity Commonwealth derives the vast majority of its income in the form of rental revenue from tenants occupying its offices.